"Philadelphia, PA, Thursday, February 24, 2005: Hemispherx Biopharma, Inc. (Amex:HEB) was highlighted on CNBC’s “Closing Bell” program yesterday in a segment on Avian Flu. Pharmaceuticals reporter Mike Huckman reported that the World Health Organization has predicted that the Avian Flu threatens to spread around the world and infect millions of people. Huckman focused on Hemispherx Biopharma as one of a few companies with a plausible potential treatment for the deadly virus.
The segment discussed the lack of any currently available treatment for Avian Flu in the marketplace, as well as the potential for a “global pandemic” anticipated by many if the virus mutates and transfers from animals to humans. Hemispherx is a drug manufacturer with two different approaches to battling Avian Flu: The company has tested Alferon N in the food and water of birds raised as poultry crops (where the virus may breed) and found it reduces mortality rates and contributes to a healthier bird population."
Is HEB just paying Richt to present this old data?